Major Bleeding Rates in Atrial Fibrillation Patients on Single DualTriple Antithrombotic Therapy

03 Jan, 2019 ,

Nienke van Rein et al conducted a nationwide cohort study of Danish atrial fibrillation patients aged 50 years or older to assess data on bleeding rates in this highrisk group that receive anticoagulant therapy and platelet aggregation inhibitors in combination The high bleeding rates observed in patients on triple therapy over the age of 90 years or with a CHA2DS2VAScscore